A well-known pathological hallmark of most forms of ALS/FTD, including C9-ALS/FTD12, is the mislocalization of TDP-43 from the nucleus, where it usually resides, to the cytoplasm. Here, TARDBP is linked to amyotrophic lateral sclerosis.